Calcium flux as a pharmacoefficacy biomarker for inhibitors...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/18 (2006.01)

Patent

CA 2683822

Described herein are methods for using calcium flux as a biomarker to select and predict patients likely to respond to an apoptotic agent as therapy. Further described herein is a method of using calcium flux as a clinical biomarker to determine whether a tumor is sensitive to an HDAC inhibitor.

La présente invention concerne des procédés d'utilisation de flux de calcium en tant que biomarqueur pour sélectionner et prédire des patients susceptibles de réagir à un agent apoptotique comme traitement. L'invention concerne également un procédé d'utilisation de flux de calcium en tant que biomarqueur clinique pour déterminer si une tumeur est sensible à un inhibiteur de HDAC.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Calcium flux as a pharmacoefficacy biomarker for inhibitors... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Calcium flux as a pharmacoefficacy biomarker for inhibitors..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Calcium flux as a pharmacoefficacy biomarker for inhibitors... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1488938

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.